Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 616,981 | 620,040 | 599,046 | 557,540 | 609,759 |
| Cost of Goods | 427,154 | 387,509 | 379,025 | 379,354 | 394,371 |
| Gross Profit | 189,827 | 232,531 | 220,021 | 178,186 | 215,388 |
| Operating Expenses | 175,788 | 157,392 | 139,962 | 144,091 | 179,727 |
| Operating Income | 14,193 | 75,648 | 80,084 | 34,449 | 36,032 |
| Interest Expense | 59,548 | 50,909 | 50,857 | 49,315 | 47,028 |
| Other Income | -38,106 | -1,782 | 433 | 5,440 | 3,341 |
| Pre-tax Income | -83,461 | 22,957 | 29,660 | -9,426 | -7,655 |
| Income Tax | 9,883 | -2,076 | -23 | 668 | -1,797 |
| Net Income Continuous | -93,344 | 25,033 | 29,683 | -10,094 | -5,858 |
| Minority Interests | 5,305 | 15,351 | 17,766 | -3,151 | -1,525 |
| Net Income | $-98,649 | $9,682 | $11,917 | $-6,943 | $-4,333 |
| EPS Basic Total Ops | -0.57 | 0.06 | 0.08 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.57 | 0.16 | 0.19 | -0.07 | -0.04 |
| EPS Diluted Total Ops | -0.57 | 0.06 | 0.08 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.56 | 0.16 | 0.19 | -0.07 | -0.04 |
| EBITDA(a) | $75,790 | $135,215 | $139,660 | $94,657 | $99,194 |